IL6 and colorectal carcinoma: Studies have shown that LPC can activate macrophages, maintain the M1 phenotype of macrophages, produce IL-12, IL-1β, TNF-α, and IL-6, and other proinflammatory factors, enhance the inflammatory response, and promote the development of CRC [30, 31].